ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
9.6K |
2.8M |
12 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
E300
|
518 |
162K |
9 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
518
|
162K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
9.6K |
2.8M |
21 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
E300
|
184 |
65K |
9 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
184
|
65K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
E300
|
184 |
65K |
7 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
184
|
65K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
E300
|
551 |
203K |
9 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
551
|
203K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
E300
|
551 |
203K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
203K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
E300
|
226 |
78K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
78K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
9.6K |
2.8M |
11 |
11/02/24 |
11/02/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Launches Entitlement Offer and Placement
|
|
E300
|
166 |
50K |
4 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
166
|
50K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
45K |
3 |
25/12/23 |
25/12/23 |
ASX - By Stock
|
185
|
45K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
45K |
2 |
25/12/23 |
25/12/23 |
ASX - By Stock
|
185
|
45K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
45K |
8 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
185
|
45K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
45K |
5 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
185
|
45K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
E300
|
185 |
45K |
6 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
185
|
45K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2023 Full Year Financial Results Webcast
|
|
E300
|
60 |
29K |
8 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
60
|
29K
|
8
|
|
ASX - By Stock
|
AMA |
Re:
Ann: Completion of Placement and Institutional Entitlement Offer
|
|
E300
|
36 |
13K |
2 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
36
|
13K
|
2
|
|
ASX - By Stock
|
AMA |
Re:
Cash Flow & Statutory P&L
|
|
E300
|
5 |
1.7K |
4 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
5
|
1.7K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
E300
|
904 |
276K |
3 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
904
|
276K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
E300
|
1.3K |
548K |
9 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
548K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
E300
|
1.3K |
548K |
34 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
548K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
E300
|
1.3K |
548K |
7 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
548K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.1M |
16 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.1M |
27 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.1M |
15 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
E300
|
901 |
280K |
5 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
901
|
280K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
E300
|
901 |
280K |
16 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
901
|
280K
|
16
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
E300
|
400 |
149K |
10 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
149K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
E300
|
400 |
149K |
6 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
149K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
E300
|
5.2K |
2.5M |
10 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
5.2K
|
2.5M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
E300
|
17K |
6.6M |
14 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
17K
|
6.6M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
E300
|
17K |
6.6M |
18 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
17K
|
6.6M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.1M |
8 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3G, Appendix 3H and Appendix 3Ys
|
|
E300
|
24 |
12K |
18 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
24
|
12K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3G, Appendix 3H and Appendix 3Ys
|
|
E300
|
24 |
12K |
14 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
24
|
12K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.1M |
6 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.1M |
9 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.1M |
1 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
E300
|
3.4K |
1.1M |
28 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
E300
|
17K |
6.6M |
11 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
17K
|
6.6M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
E300
|
17K |
6.6M |
11 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
17K
|
6.6M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Director Appointed to Strategic Advisory Role
|
|
E300
|
106 |
44K |
8 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
106
|
44K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
9.6K |
2.8M |
16 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
9.6K
|
2.8M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
9.6K |
2.8M |
5 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
9.6K
|
2.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
9.6K |
2.8M |
15 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
9.6K
|
2.8M
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
E300
|
400 |
149K |
18 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
400
|
149K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
E300
|
362 |
113K |
18 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
362
|
113K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Third Quarter Financial Results Webcast
|
|
E300
|
38 |
15K |
10 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
38
|
15K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
E300
|
17K |
6.6M |
14 |
13/05/23 |
13/05/23 |
ASX - By Stock
|
17K
|
6.6M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
E300
|
9.6K |
2.8M |
17 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
9.6K
|
2.8M
|
17
|
|